The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 331:481-482 August 18, 1994 Number 7
NextNext

Trifluridine for Herpes Zoster

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Rosencrance, G.
To the Editor: In the Images in Clinical Medicine section (March 31 issue),1 Rosencrance presents an excellent clinical photograph of herpes zoster involving the right trigeminal nerve. He mentions that the patient was treated with intravenous acyclovir, as well as trifluridine and sulfacetamide-prednisolone eyedrops. I am aware of no study supporting the use of trifluridine for the treatment of herpes zoster keratitis2. Topical trifluridine is extremely expensive, causes side effects such as superficial punctate keratopathy and epithelial defects, and is indicated only for the treatment of external eye infections caused by herpes simplex virus. Although herpes zoster uveitis and . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.